Registry of Outcomes of Dezawa MuseCells®
Part of paid clinical trials in North Palm Beach, Florida.
- Sponsor
- MuseCell Innovations Pte LTD
- Study ID
- NCT07645989
- Status
- Recruiting
Conditions
- Longevity
- Orthopaedic
- Osteoarthritis (OA)
- Pain
- Wound Care
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- MuseCell Treatment — OTHERPatients undergoing treatment with Dezawa MuseCells
Study Details
The goal of this observational study is to learn about the long-term effects of Dezawa MuseCells to treat various diseases. The Primary Goal: What is the short-term and long- term outcomes of Dezawa Musecells? Participants treated with Dezawa MuseCells as part of their regular medical care and will answer online survey questions about symptoms and clinical outcomes for 5 years.
Key Dates
- Start date
- Jul 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Jul 1, 2031
- Completion
- Dec 31, 2031
Study Design
- Enrollment
- 5,000 participants (estimated)
Arms
- Arm: OrthopaedicPatients undergoing treatment for orthopaedic conditions
- Arm: LongevityPatients undergoing treatment for longevity and inflammation
- Arm: Wound CarePatients undergoing treatment to treat wounds
- Arm: PainPatients undergoing treatment for various pain conditions
Primary Outcome Measure
Change in Patient Reported Symptom Severity [ Time Frame: Baseline; 1 month; 3 months; 6 months; 12 months; annually through 5 years. ]
Central Contacts
- MuseCell Information+65 80166929
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Bioreset Medical | North Palm Beach | Florida | 33408 | Matt Cook, MD (SUB_INVESTIGATOR) Jeffrey Wiegers, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in North Palm Beach, FL
By research site
Related Studies
- RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for PainRecruiting · Boston Scientific Corporation · Phoenix, Arizona
- Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect DeterminationEARLY_PHASE1 · Recruiting · University of Florida · Gainesville, Florida
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Pervasive Sensing and AI in Intelligent ICURecruiting · University of Florida · Gainesville, Florida